EXPERIENCE WITH DESLORATADINE IN PATIENTS WITH AUTOIMMUNE URTICARIA

Desloratadine is an effective histamine H1 receptor blocker in the complex treatment of patients with various allergic diseases. The article presents literature data on the clinical efficacy and safety of desloratadine in the treatment of autoimmune urticaria of various etiologies and courses.

Publication Details

Journal: Zenodo (CERN European Organization for Nuclear Research)
Published: 2025-02-10
DOI: https://doi.org/10.5281/zenodo.14844374
Primary Topic: Urticaria and Related Conditions
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

EXPERIENCE WITH DESLORATADINE IN PATIENTS WITH AUTOIMMUNE URTICARIA

Feb 10, 2025

Zenodo (CERN European Organization for Nuclear Research)

Urticaria and Related Conditions

article

EXPERIENCE WITH DESLORATADINE IN PATIENTS WITH AUTOIMMUNE URTICARIA

February 10, 2025article en

Abstract

Zenodo (CERN European Organization for Nuclear Research)

Good health and well-being

Openalex Percentile: Top 38%

Urticaria and Related Conditions

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

EXPERIENCE WITH DESLORATADINE IN PATIENTS WITH AUTOIMMUNE URTICARIA · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS